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Prothymosin a overexpression contributes to the
development of pulmonary emphysema
Bing-Hua Su1,2,*, Yau-Lin Tseng3,*, Gia-Shing Shieh4, Yi-Cheng Chen1, Ya-Chieh Shiang1, Pensee Wu5,
Kuo-Jung Li1, Te-Hsin Yen6, Ai-Li Shiau2,6 & Chao-Liang Wu1
Emphysema is one of the disease conditions that comprise chronic obstructive pulmonary
disease. Prothymosin a transgenic mice exhibit an emphysema phenotype, but the patho-
physiological role of prothymosin a in emphysema remains unclear. Here we show that
prothymosin a contributes to the pathogenesis of emphysema by increasing acetylation of
histones and nuclear factor-kappaB, particularly upon cigarette smoke exposure. We ﬁnd a
positive correlation between prothymosin a levels and the severity of emphysema in
prothymosin a transgenic mice and emphysema patients. Prothymosin a overexpression
increases susceptibility to cigarette smoke-induced emphysema, and cigarette smoke expo-
sure further enhances prothymosin a expression. We show that prothymosin a inhibits the
association of histone deacetylases with histones and nuclear factor-kappaB, and that
prothymosin a overexpression increases expression of nuclear factor-kappaB-dependent
matrix metalloproteinase 2 and matrix metalloproteinase 9, which are found in the lungs of
patients with chronic obstructive pulmonary disease. These results demonstrate the clinical
relevance of prothymosin a in regulating acetylation events during the pathogenesis of
emphysema.
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E
mphysema, the major consequence of chronic obstructive
pulmonary disease (COPD), is characterized by permanent
airﬂow restriction resulting from enlargement of alveolar
airspace and loss of lung elasticity1. Cigarette smoking is
associated with the severity of emphysema, which also
correlates with the degree of progressive pulmonary
inﬂammation2. Although cigarette smoking is the main risk
factor, only about 25% of smokers develop emphysema3.
Therefore, there may be unidentiﬁed genetic or host factors
that predispose individuals to emphysema.
Prothymosin a (ProT) is a highly acidic nuclear protein, the
sequence of which is highly conserved from unicellular organisms
to humans; this implies its essential role in cell function4,5. ProT
possesses diverse intracellular and extracellular functions that
are involved in proliferation, apoptosis, oxidative stress, immuno-
modulation and acetylation6–11. ProT can bind to the linker
histone H1 (refs 12,13) and core histones14, thereby modulating
the chromatin structure. As chromatin remodelling is regulated
by the acetylation and deacetylation of histones, recent studies
have explored the acetylation-regulating role of ProT. ProT can
interact with two different histone acetyltransferases (HATs):
CREB-binding protein (CBP) and p300 (refs 15,16). ProT
stimulates AP1- and NF-kB-dependent transcription through
interaction with CBP17. Moreover, overexpression of ProT elicits
a p53 response that involves p53 acetylation18.
Although ProT appears to be involved in multiple cellular
functions, its exact physiological role remains poorly understood.
We have generated ProT transgenic mice that exhibit the
polycystic kidney disease phenotype, which is characterized
by the development of renal cysts and progressive renal
dysfunction19, as well as emphysema-like changes in the lung.
However, the pathophysiological role of ProT in pulmonary
emphysema remains unknown. The aim of this study was to gain
insight into the molecular mechanisms underlying the action of
ProT on the development of emphysema, particularly under the
stimulation of cigarette smoke (CS). Our results from animal
models and clinical patients support an important role for ProT
in the development of emphysema. We show that ProT can
enhance the acetylation of histones and nuclear factor-kappaB
(NF-kB), leading to activating NF-kB and upregulating NF-kB-
dependent pro-inﬂammatory gene expression, including matrix
metalloproteinase 2 (MMP2) and matrix metalloproteinase 9
(MMP9). Our ﬁndings elucidate the pathophysiological role of
ProT and identify a potential novel molecular mechanism in the
pathogenesis of COPD.
Results
ProT overexpression leads to an emphysema-like phenotype.
ProT homozygous (HZ) transgenic mice spontaneously devel-
oped pulmonary emphysema characterized by alveolar airspace
enlargement and alveolar wall destruction, whereas heterozygous
(HET) mice had only mild disease (Fig. 1a, left). The average
airspace in the HZ mice was four-fold greater than that in the
non-transgenic (NT) littermates (Fig. 1b, right). HZ mice died at
10 days postpartum, whereas heterozygotes appeared normal and
lived their normal life span19. The overexpression of ProT was
conﬁrmed immunohistochemically in the emphysematous tissues
of the transgenic mice (Fig. 1b). There was a positive correlation
between ProT levels and the severity of emphysema, as assessed
by airspace enlargement (Fig. 1c).
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Figure 1 | Overexpression of ProT in transgenic mice and in the lung epithelium of patients with emphysema. (a) H&E-stained lung sections of
4-day-old ProT HZ, HET and NT mice (left) and quantitative analysis of alveolar airspace enlargement (right). Scale bars shown on  100 and  200
images correspond to 100 and 50mm, respectively. Average airspace area was calculated by dividing the total airspace by the total number of alveoli in
three randomly selected ﬁelds at  200 magniﬁcation in each section. Values (mean±s.e.m., n¼ 3; Student’s t-test) shown are relative airspace area,
with the value of NTmice arbitrarily set to 100. Arrow denotes alveolar wall destruction. (b) Immunohistochemistry (left) and quantitation (right) of ProT in
the lung sections of mice. Its immunoreactive intensity (mean±s.e.m., n¼ 3; Student’s t-test) was analysed by MetaMorph software. Scale bars shown
on 400 images correspond to 20mm, and the boxed areas are magniﬁed below each panel. (c) A positive correlation (P¼0.0079; Pearson’s correlation
coefﬁcient) between the levels of ProT immunoreactivity and airspace enlargement. (d) Immunohistochemistry (right) and quantitation (left) of
ProT in lung tissues from patients with emphysema of varying severity and non-COPD individuals. Scale bars shown on  100 and  500 images
correspond to 200 and 100mm, respectively, and the boxed areas are magniﬁed below each panel. Values shown are levels of ProT immunoreactivity in
individual specimens, with the mean level in normal tissues arbitrarily set to 100, in three randomly selected ﬁelds at  500 magniﬁcation in each section;
horizontal bars represent the mean (n¼4–8; Student’s t-test). Results are representative of three independent experiments.
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ProT is overexpressed in the lung of emphysema patients. To
further explore whether emphysema induced by ProT over-
expression in transgenic mice resembled human emphysema, we
examined 20 clinical specimens from patients with varying
degrees of pulmonary emphysema—15 smokers and 5 non-
smokers—for ProT expression (Supplementary Table S1). The
patients had been diagnosed with emphysema on the basis of
pulmonary function test results, computed tomography (CT)
scans and pathological reports from resected lung specimens.
Overall, ProT was overexpressed in 19 (95%) of the 20 emphy-
sematous specimens. However, it was expressed only weakly in
four non-tumourous, normal lung tissues obtained from lung
cancer patients who were cigarette smokers without COPD
(Fig. 1d, left, Supplementary Fig. S1a,b, Supplementary Table S1).
These results further support the involvement of ProT in
emphysema. Notably, with regard to the intensity of ProT
immunoreactivity, the degree of ProT expression was positively
correlated with the severity of emphysema in the patients (Fig. 1d,
right, Supplementary Table S1).
ProT transgenic mice are susceptible to CS-induced
emphysema. Given that CS is the main risk factor for emphysema,
we next investigated whether treatment with CS extract (CSE)
resulted in overexpression of ProT. We analysed the microarray
data20 (Gene Expression Omnibus (GEO) accession number
GPL96, Data Set Record GDS737) obtained from the GEO, NCBI
and found that smokers with severe emphysema had signiﬁcantly
higher levels of ProT expression in the lungs than smokers with
mild or no emphysema (Supplementary Fig. S2). These data
suggest that ProT may predispose individuals to CS-induced
emphysema. We further investigated this issue using a mouse
model of emphysema induced by CSE. We successfully established
an emphysema model using wild-type FVB mice treated with CSE
for 5 to 7 weeks (Supplementary Fig. S3). We demonstrated that,
like rats, as previously reported21, mice can serve as a useful
animal model of CSE-induced emphysema that closely resembles
the form produced in rats and is similar to that found in humans.
To determine the role of ProT in the susceptibility of mice
to CSE-induced emphysema, we exposed ProT HET and NT mice
to CSE and examined their lungs for airspace enlargement.
Immunohistochemical examination (Fig. 2a, left) and
quantiﬁcation of the immunoreactive intensity (Fig. 2a, right)
conﬁrmed that the ProT levels in ProT transgenic mice were
higher than in NT mice and increased further after CSE treatment
(Fig. 2a, right). As shown in Fig. 2b (left), 27% of the ProT
transgenic mice spontaneously developed emphysema, whereas
none of the NT mice developed the disease. However, treatment
with CSE dramatically increased the incidence of emphysema,
with 100% of ProT heterozygotes and 67% of NT mice exhibiting
airspace enlargement. Furthermore, the transgenic mice had
more severe disease than the NT mice after CSE treatment
(Fig. 2b, middle, right). To further support the physiological
association of ProT with the development of emphysema, we
delivered lentiviral vectors expressing ProT short hairpin RNA
(shRNA) into the lungs of wild-type FVB mice to knockdown
the endogenous ProT expression (Fig. 2c, left, right). This resulted
in concomitant decreases in the incidence (Fig. 2d, left) and
severity (Fig. 2d, middle, right) of emphysema after CSE
treatment. Collectively, these results highlight the importance
of ProT in the development of emphysema and further
suggest that overexpressed ProT in the lung may increase
susceptibility to emphysema either related or unrelated to CS
exposure.
ProT inhibits histone deacetylases. Given the decreased histone
deacetylases (HDAC) activity in the peripheral lungs and alveolar
macrophages in COPD patients, and the resulting ampliﬁcation
of pro-inﬂammatory gene expression through increased histone
acetylation2,22, we investigated whether HDACs were affected in
the lungs of emphysema patients and ProT transgenic mice.
Immunohistochemical examination revealed lower levels of
HDAC2 expression in the lung epithelia of patients with more
severe emphysema, despite little change in HDAC1 and HDAC3
levels (Fig. 3a). Similar expression patterns of HDACs were noted
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Figure 2 | ProT is involved in CSE-induced emphysema in mice. (a,b) Six-week-old ProT HET and NT mice were injected intraperitoneally with CSE or
saline twice a week for 6 weeks. (c,d) Six-week-old FVB mice were intratracheally injected with lentiviral vectors expressing ProT or luciferase (Luc)
shRNA followed by intraperitoneal injections of CSE or saline twice a week for 6 weeks. Subsequently, their lung sections were immunostained for ProT
(a,c) and H&E stained for examining alveolar airspace enlargement (b,d), as described in Figure 1. The boxed areas in upper panels (original magniﬁcation
400; Scale bar¼ 100mm) are magniﬁed and shown in lower panels (a,c) and scale bars on  100 and  200 images correspond to 100 and
50mm, respectively (b,d). Histological changes in the lungs were evaluated for the incidence of emphysema in ProT transgenic or NT mice (0 of 13 for
NT-Saline, 3 of 11 for HET-Saline, 10 of 15 for NT-CSE and 10 of 10 for HET-CSE; Po0.0001 between any two of the four treatment groups analysed
by the w2-test) (b), and in ProT knockdown mice (0 of 6 for Luc shRNA-Saline, 0 of 6 for ProTshRNA-Saline, 6 of 9 Luc shRNA-CSE and 1 of 7 ProTshRNA-
CSE; Po0.0001 between any two of the four treatment groups analysed by the w2-test) (d). All immunohistochemical and histochemical data
(mean±s.e.m., n¼ 3; Student’s t-test) are representative of three independent experiments.
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in ProT transgenic mice, particularly in the homozygotes, as
detected by immunohistochemistry (Fig. 3b) and immunoblotting
(Fig. 3c).
As ProT can interact with histones12–14 and CBP/p300
(refs 15,16), it may affect chromatin remodelling processes and
regulate transcription. Overexpressed ProT has been shown to
elicit a p53 response that involves acetylation of p53 at residues
known to be acetylated by CBP/p300 (ref. 18). We hypothesized
that ProT may be involved in the regulation of protein acetylation
that contributes to the development of emphysema. We used
overexpression and knockdown experiments to study whether
ProT could mediate protein acetylation. E1A and SV40 large
T antigen, which are constitutively expressed in 293 T cells,
can bind CBP/p300 and reduce the amount of active CBP/p300
(refs 23,24). Therefore, the p300 deletion mutant lacking the
CH3 interaction domain (missing amino acids 1737–1836) was
employed for transfection to 293T cells given its well-deﬁned
inability to interact with E1A and SV40 large T antigen. In p300-
overexpressing 293T cells, overexpressed ProT dramatically
increased lysine acetylation in a large number of proteins
(Fig. 3d, left), whereas knockdown of endogenous ProT
dramatically suppressed acetylation events (Fig. 3d, right).
These ﬁndings suggest that ProT may have a global role in
protein acetylation. We further showed that overexpression of
ProT not only enhanced the acetylation of histone H1 and H3
(Fig. 3e), but also decreased the association of HDAC1 (Fig. 3f,
left) and HDAC2 (Fig. 3f, right) with histones H1 and H3. These
results suggest that ProT may enhance protein acetylation by
inhibiting the binding of HDACs to histones (Fig. 3g).
ProT increases protein acetylation in the emphysematous lung.
We further investigated whether ProT-mediated increases in
protein acetylation found in cultured cells could also be detected
in ProT transgenic mice and emphysema patients. The intracel-
lular levels of acetylated-lysine (acetyl-K) in the lung epithelium
were signiﬁcantly higher in homozygotes than in heterozygotes
(Fig. 4a). Furthermore, there was a positive correlation between
the levels of ProT and those of acetyl-K in the transgenic mice
(Fig. 4b). With the exception of two clinical specimens of mild
emphysema that showed single-positive staining for either ProT
or acetyl-K, 18 of the 20 clinical specimens of emphysema were
found to be immunoreactive for both ProT and acetyl-K (Fig. 4c,
Supplementary Figs 1a,1b,4a,4b). Notably, higher levels of acet-
ylation were visualized in the nuclei of cells from patients with
severe emphysema (Fig. 4c, upper). Quantiﬁcation of the
immunoreactive intensity revealed higher acetyl-K levels in
patients with more severe emphysema than in those with mild
emphysema (Fig. 4c, lower). Immunoﬂuorescence staining
demonstrated nuclear colocalization of acetyl-K with ProT in the
specimens from patients with severe emphysema (Fig. 4d). This
suggests that ProT is involved in lysine acetylation events. Fur-
thermore, there was a positive correlation between the expression
levels of ProT and those of acetyl-K in the clinical specimens
(Fig. 4e). ProT HET mice showed higher levels of acetyl-K
compared with NT littermates, which were further increased after
CSE treatment (Fig. 4f).
To further verify the physiological importance of ProT in the
CSE-induced enhancement of acetylation events, we knocked
down endogenous ProT in the mouse lung. Results from
immunohistochemistry (Fig. 4g, left) and quantitative analysis
(Fig. 4g, right) revealed that suppression of endogenous ProT
resulted in the attenuation of CSE-induced enhancement of
acetyl-K levels. Notably, a higher degree of lysine acetylation
corresponded to a more severe enlargement of alveolar airspace
(Fig. 4f,g). Collectively, these results strongly indicate the
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Figure 3 | Overexpression of ProT inhibits HDACs and enhances protein acetylation. (a,b) Immunohistochemical staining for HDACs. Lung tissues from
patients with emphysema of varying severity and non-COPD individuals (a), as well as lung tissues from 4-day-old ProT HZ, HET and NTmice (b) were
immunostained with monoclonal antibody against HDAC1, HDAC2 and HDAC3. Note that lower levels of HDAC2, but not HDAC1 and HDAC3, were
detected in patients with more severe emphysema and in ProT HZ mice, as compared with their normal counterparts. The boxed areas in upper panels
(original magniﬁcation 400; scale bar¼ 100mm) are magniﬁed and shown in lower panels. (c) Immunoblot analysis of HDACs in the lung tissues of
4-day-old ProT HZ, HETand NTmice. (d) Detection of acetylated-lysine (acetyl-K). 293Tcells that had been transfected with pcDNA3.1-ProT-myc/His or
pcDNA3.1 (left) or transduced with lentiviral vectors expressing ProT shRNA-1 and -2 or GFP shRNA (right) were transfected with a p300 expression
plasmid (pCMVb p300 HA tag) or a control plasmid (pHM6-lacZ). After 24 h, total cell lysates were examined for the indicated proteins by
immunoblotting. Equal levels of p300 and LacZ expression were veriﬁed. (e) Detection of acetylated histones. 293Tcells were transfected with pcDNA3.1-
ProT-myc/His or pcDNA3.1 and their total cell lysates were examined for the indicated proteins by immunoblotting after 24 h. (f) HDAC and histone
binding assay. 293T cells that had been transduced with HDAC1-Flag (pcDNA3.1-HDAC1-Flag) (left) or HDAC2-Flag (pCMV-Tag4C-HDAC2) (right) were
transfected with pcDNA3.1-ProT-myc/His or pcDNA3.1. Total cell lysates were immunoprecipitated by Flag-M2 beads and analysed by immunoblotting for
the indicated proteins. Whole-cell lysates without immunoprecipitation (10% input) were estimated for the expression levels of histone H1 and H3, HDAC1,
HDAC2 and ProT by immunoblotting. (g) Proposed model for ProT-mediated enhancement of histone acetylation via HDAC/histone dissociation. Results
are representative of three independent experiments.
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involvement of ProT in regulating protein acetylation in
emphysema in general and in CS-mediated emphysema in
particular.
ProT regulates NF-jB acetylation in emphysema. Given that
ProT can regulate the transcriptional activity of NF-kB through
interaction with CBP17 and that activity of NF-kB is post-
translationally regulated by HAT-mediated acetylation and
repressed by HDACs, especially HDAC3 (ref. 25), we next
explored whether ProT has a role in regulating NF-kB acetylation
in emphysema. Overexpression of ProT increased acetylation of
NF-kB RelA/p65 subunit at Lys310, which is required for its full
transactivation function26 (Fig. 5a, left) and the transcriptional
activity of NF-kB (5b, left), whereas knockdown of endogenous
ProT abolished such effects (Fig. 5a, right, Fig. 5b, right).
Moreover, the direct interaction of endogenous p65 with ProT
was veriﬁed in 293T cells overexpressing ProT (Fig. 5c). As ProT
could regulate histone acetylation by inhibiting the association of
HDACs with histones (Fig. 3f), we next examined whether the
ProT-mediated enhancement of NF-kB acetylation could be
ascribed to the same mechanism. Immunoprecipitation with
anti-Flag antibody and immunoblotting with HDAC3 antibody of
293T cells cotransfected with ProT-myc/His vector and NF-kB
p65-Flag vector revealed that overexpression of ProT reduced the
interaction of NF-kB with HDAC3, as a lower amount of HDAC3
was pulled down along with p65 in ProT-overexpressing cells
compared with the corresponding control cells (Fig. 5d, left). In
reverse immunoprecipitation, similar results were obtained in
cells cotransfected with ProT-myc/His vector and HDAC3-Flag
vector, showing that a lower amount of p65 was pulled down
along with HDAC3 (Fig. 5d, right). As ProT could interact with
p65 (Fig. 5c) and enhance its acetylation (Fig. 5a), we further
investigated whether ProT could affect the interaction of p300
with NF-kB. Figure 5e shows that knockdown of endogenous
ProT attenuated the interaction of p300 with NF-kB, as a lower
amount of p65 was pulled down along with p300 in ProT
knockdown cells that had been cotransfected with p300 HA and
NF-kB p65-Flag vectors. Collectively, these results indicate that
ProT can increase NF-kB acetylation both by depriving HDACs
from NF-kB and by facilitating the recruitment of p300 to NF-kB
(Fig. 5f).
We further investigated whether ProT-mediated NF-kB
acetylation at Lys310 was associated with emphysema.
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Figure 4 | Overexpression of ProT increases protein acetylation in emphysematous lungs of mice and patients. (a) Immunohistochemistry (left) and
quantitation (right) of acetylated-lysine (acetyl-K) in lung tissues of 4-day-old ProT HZ, HETand NTmice. (b) A positive correlation (P¼0.0012; Pearson’s
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immunoreactive levels in individual specimens; horizontal bars represent the mean. (d) Immunoﬂuorescence microscopy. Lung tissues from patients with
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against acetyl-K followed by Alexa Fluor 594-conjugated goat anti-mouse IgG and FITC-conjugated goat anti-rabbit IgG. Nuclei were counterstained
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correlation (Po0.0001; Pearson’s correlation coefﬁcient) between the levels of ProT immunoreactivity and those of acetyl-K immunoreactivity.
(f,g) Immunohistochemistry (left) and quantitation (right) of acetyl-K in lung tissues from ProT HETand NTmice that were injected intraperitoneally with
CSE or saline twice a week for 6 weeks (f) and from FVB mice that had been intratracheally injected with lentiviral vectors expressing ProT or luciferase
(Luc) shRNA followed by intraperitoneal injections of CSE or saline twice a week for 6 weeks (g). Acetyl-K immunoreactive intensity (mean±s.e.m.;
Student’s t-test) was analysed in three randomly selected ﬁelds at 400 magniﬁcation in each section by MetaMorph software (n¼ 3 in (a,f,g); n¼4–8 in
c). Values shown are relative acetyl-K intensity levels, with the level in normal tissues arbitrarily set to 100. Scale bar¼ 20mm, and the boxed areas in upper
panels (original magniﬁcation 400) are magniﬁed and shown in lower panels. Results are representative of three independent experiments.
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Increased acetyl-NF-kB expression was detected in the lung
epithelia of ProT transgenic mice, in particular in the
homozygotes (Fig. 6a), and of patients with emphysema
(Fig. 6b). Notably, patients with more severe emphysema
appeared to have higher levels of acetyl-NF-kB (Fig. 6b). The
contribution of ProT in mediating NF-kB acetylation in vivo was
further veriﬁed by ProT knockdown experiments in wild-type
FVB mice. The knockdown of endogenous ProT in the lungs via
intratracheal administration of lentiviral vectors expressing ProT
shRNA reduced CSE-mediated NF-kB acetylation (Fig. 6c).
Immunoﬂuorescence staining showed that treatment with CSE
increased the nuclear translocation of NF-kB, which colocalized
with ProT, in the lungs of ProT HET mice (Fig. 6d) and in mouse
lung epithelial MLE 12 cells transduced with ProT (Fig. 6e).
Taken together, these results indicate that ProT can regulate the
acetylation and activity of NF-kB in emphysematous lungs, which
is likely through its dual effect of increasing the association of
p300 with NF-kB and decreasing the association of HDACs with
NF-kB.
ProT regulates the production of MMP2 and MMP9 in
emphysema. Abnormal production of MMPs is implicated in the
pathogenesis of emphysema. Human studies have also demon-
strated oversecretion of MMP2 and MMP9 in patients with
COPD27. As the promoter regions of MMP2 and MMP9 contain
binding sites for NF-kB and their expression is regulated by
NF-kB (refs 28–30), we examined whether the production of
MMP2 and MMP9 was regulated by ProT in emphysema. Higher
levels of MMP2 and MMP9 proteins were detected in human
emphysematous tissues than in normal tissues (Fig. 7a). In the
mouse lung tissue, ProT transgenic mice exhibited increased
expression of MMP2 and MMP9 proteins (Fig. 7b) and mRNA
(Fig. 7c), compared with NT littermates. Gelatin zymography also
revealed higher MMP2 and MMP9 activity in the HZ mouse
embryonic ﬁbroblasts (Fig. 7d). Moreover, overexpression of
ProT in 293T cells upregulated the mRNA expression of MMP2
and MMP9 (Fig. 7e). Analysis of microarray data from the lung
tissues of smokers with severe emphysema from GEO20 also
revealed a positive correlation between the expression levels of
ProT and those of MMP2, as well as between the expression levels
of ProT and those of MMP9 (Supplementary Fig. S5).
Furthermore, immunohistochemical staining demonstrated that
the expression of MMP9 was higher in the lungs of ProT
transgenic mice and that CSE treatment upregulated MMP9
expression in both ProT transgenic and NT mice (Fig. 7f).
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with pcDNA3.1-ProT-myc/His or pcDNA3.1 (left) or transduced with lentiviruses expressing ProT shRNA-1 and -2 or GFP shRNA (right) were transfected
with a p300 expression vector (pCMVb p300 HA delta33) or a control vector (pHM6-lacZ). After 24 h, total cell lysates were examined for the indicated
proteins by immunoblotting. Equal levels of p300 and LacZ expression in the transfected cells were veriﬁed. (b) Reporter assay for NF-kB transactivation
activity. 293T cells that had been transduced with lentiviruses expressing ProT-IRES-GFP or GFP alone (left), or ProT or GFP shRNA (right) were
cotransfected with pNF-kB-Luc and pTK-Renilla reporter plasmids. Total cell lysates were harvested 48 h later, and their ﬁreﬂy and Renilla luciferase
activities were determined. The ratio of ﬁreﬂy luciferase activity to Renilla luciferase activity was expressed as relative light activity. Values shown are the
mean±s.e.m. (n¼4 for left and n¼ 5 for right; Student’s t-test). (c) NF-kB and ProT binding assay. Cell lysates from 293T cells transduced with
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kB p65 and anti-GFP antibody. Whole-cell lysates without immunoprecipitation (10% input) were estimated for the expression levels of NF-kB and ProT by
immunoblotting. (d) Analysis of the effect of ProTon NF-kB and HDAC3 binding. 293Tcells that had been transfected with an NF-kB p65 expression vector
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(right) were transfected with pcDNA3.1-ProT-myc/His or pcDNA3.1. After 24 h, total cell lysates were immuoprecipitated by Flag-M2 beads followed by
immunoblotting with the indicated proteins. Whole-cell lysates without immunoprecipitation (10% input) were estimated by immunoblotting with
indicated proteins. (e) p300 and NF-kB binding assay. 293Tcells that had been transduced with lentiviruses expressing ProTshRNA-2 or luciferase shRNA
as the control were transfected with the pCMVb p300 HA delta33 and pcDNA3-cFlag-RelA. Total cell lysates were immunoprecipitated by anti-HA
antibody followed by immunoblotting with the indicated proteins. Results are representative of three independent experiments. (f) Proposed model for
ProT-mediated NF-kB hyperacetylation via HDAC3/NF-kB dissociation and p300/NF-kB association.
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Conversely, lentivirus-mediated knockdown of endogenous ProT
in the lungs of wild-type FVB mice reduced the expression of
MMP9, as compared with the control mice that received Luc
shRNA, in CSE-induced emphysema (Fig. 7g). Collectively, these
results indicate that ProT has a role in the regulation of NF-kB-
dependent MMP2 and MMP9 production in the pathogenesis of
emphysema.
We further investigated whether NF-kB-binding sites were
involved in ProT-induced MMP2 and MMP9 expression. A
chromatin immunoprecipitation (ChIP) assay revealed that
overexpression of ProT increased the binding of NF-kB to the
MMP2 and MMP9 promoters (Fig. 7h). Furthermore, ProT could
directly bind to the NF-kB binding site-containing region within
MMP2 and MMP9 promoters (Fig. 7i). These ﬁndings
demonstrate the functional importance of ProT-induced
binding of NF-kB to MMP2 and MMP9 promoters. Our data
suggest that ProT can occupy NF-kB-dependent promoters and
directly increase NF-kB acetylation, thereby enhancing the
transcriptional activation of NF-kB on MMP2 and MMP9
promoters. Taken together, our results demonstrate that
overexpressed ProT associates with MMP2 and MMP9
promoters and results in increased levels of acetylated NF-kB at
the promoters, which is associated with CS-mediated production
of MMP2 and MMP9.
Discussion
CS is the main risk factor for emphysema, acting through the
acetylation-mediated enhancement of chromatin remodelling in
pro-inﬂammatory genes2,31. However, other factors, including
genetic or host factors, may also be important in the development
of emphysema. We tested the hypothesis that ProT regulates
acetylation events and hence has a critical role in predisposing
individuals to develop emphysema. In this study, we
demonstrated for the ﬁrst time the correlation between ProT
and emphysema in both clinical patients and ProT transgenic
mice. Our results indicate that overexpression of ProT in the lung
is correlated with severity of emphysema in clinical patients. In
animal models, ProT HZ transgenic mice exhibited spontaneous
airspace enlargement and alveolar wall destruction, which are
characteristics of emphysema. The HET mice had only mild
airspace enlargements; however, treatment with CSE signiﬁcantly
increased the incidence and severity of emphysema with
concomitant enhancements in ProT expression. We also
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Figure 6 | Overexpression of ProT increases NF-jB acetylation in emphysematous lungs of mice and patients. (a–c) Immunohistochemical detection of
acetyl-NF-kB p65 in lung tissues from 4-day-old ProT HZ, HET and NT mice (a), from patients with emphysema of varying severity and non-COPD
individuals (b) and from FVB mice that had been intratracheally injected with lentiviral vectors expressing ProT or luciferase (Luc) shRNA followed by
intraperitoneal injections of CSE or saline twice a week for 6 weeks (c). Note that positive nuclear staining for acetyl-NF-kB p65 in the lung epithelium
of ProT transgenic mice was observed (a) and that higher levels of acetyl-NF-kB p65 accumulation were detected in patients with more severe
emphysema (b). The boxed areas in upper panels (original magniﬁcation 400; Scale bar¼ 20mm) are magniﬁed and shown in lower panels.
(d,e) Immunoﬂuorescence microscopy. Lung tissues from ProT HET and NTmice that had been injected intraperitoneally with CSE or saline twice a week
for 6 weeks (d) and mouse lung epithelial MLE 12 cells that had been transduced with ProT and GFP by lentiviral vectors Lenti-ProT and Lenti-GFP,
respectively, and then treated with CSE or saline (e) were incubated with mouse monoclonal antibody against ProT and rabbit polyclonal antibody against
NF-kB p65 or acetyl-NF-kB p65 (Lys310) followed by Alexa Fluor 594-conjugated goat anti-mouse IgG and Alexa Fluor 488-conjugated goat anti-rabbit
IgG. Nuclei were counterstained with DAPI. Fluorescence signals for ProT (red), NF-kB p65 (green), acetyl-NF-kB p65 (green) and the nucleus (blue) were
examined by ﬂuorescence microscopy. Scale bar¼ 10 mm; original magniﬁcation 400. Results are representative of three independent experiments.
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showed that the increase in airspace enlargement was associated
with elevated levels of acetylated NF-kB (p65 Lys310) that
colocalized with ProT in the nucleus and with increased
MMP2 and MMP9 levels in the lungs of ProT transgenic
mice. More signiﬁcantly, our RNA interference experiments
veriﬁed that endogenous ProT affects NF-kB acetylation
and MMP production in the development of emphysema,
especially upon exposure to CS. These results clearly indicate
the clinical relevance of ProT in the development of pulmonary
emphysema.
The balance between protein acetylation and deacetylation that
maintains cellular homeostasis is determined by the HAT/HDAC
interplay. Previous studies have demonstrated that ProT is
involved in chromatin remodelling by binding to histones as
well as by recruiting and stabilizing HAT CBP/p300 coactivators,
thus regulating gene transcription12,14,16,17. In this study, we
further demonstrated that in addition to histones, ProT has a role
in the post-translational acetylation of non-histone proteins,
including NF-kB (p65 Lys310) involved in regulating the
expression of pro-inﬂammatory genes in COPD. Moreover, we
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observed decreases in HDAC2 levels, which correlated with
disease severity, but no detectable changes in HDAC1 and
HDAC3 proteins in the lungs of emphysema patients or ProT
transgenic mice. These results are consistent with a previous
report showing a marked reduction in the HDAC2 expression in
the lungs of COPD patients22. Surprisingly, we also found that
ProT is capable of inhibiting the interaction of HDAC2 or
HDAC1 with histones. Furthermore, ProT can directly bind to
NF-kB and enhance its acetylation by displacing HDAC3 from its
complex with NF-kB. As HDAC1 and HDAC2 can also interact
with RelA/p65 and inhibit its transactivation32, ProT also
probably affects these two HDACs through the same
mechanism. We demonstrated for the ﬁrst time that ProT can
inhibit class I HDACs, including HDAC1, 2 and 3, and thereby
enhance the acetylation of histones and NF-kB. Our results from
animal models and clinical patients strongly suggest a potential
novel model whereby excess ProT causes a shift in the HAT/
HDAC balance toward HAT in the emphysematous lung, which
supports an important role for ProT in the pathogenesis of
emphysema. We propose that the mechanisms of ProT action in
combination with CS exposure in emphysema underlie the
hyperacetylation of chromatin and NF-kB, leading to
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upregulation of NF-kB-dependent gene expression, such as
MMP2 and MMP9 (Fig. 8). Reduction of other deacetylases,
such as SIRT1, has been found in macrophages and in the lungs of
smokers and COPD patients, and it leads to increased acetylation
and activation of p65 (ref. 33). As many proteins are subject to
lysine acetylation, which can modulate protein interaction, DNA
binding and subcellular localization, it is tempting to speculate
that ProT may affect their functions through the regulation of
the HAT/HDAC balance. It is conceivable that, in addition to
the acetylation of the histones and NF-kB that regulate these
inﬂammatory responses, other unidentiﬁed molecules and
pathways are also affected by overexpressed ProT and contribute
to the pathogenesis of emphysema.
NF-kB is involved in many pathways, including inﬂammation,
cell survival, proliferation and differentiation. The typical NF-kB
pathway is characterized by activation of p50/p65 heterodimers to
transactivate pro-inﬂammatory gene expression34. Homodimers
of the p50 subunit, which lack transactivation domains, can
repress NF-kB target gene expression. Gene knockout studies have
shown that NF-kB can have both pro-inﬂammatory and anti-
inﬂammatory roles that are probably involved in the resolution of
inﬂammation35. The p65 knockout mice were embryonically
lethal; however, p50 knockout mice that are HET for p65 were
more susceptible to lipopolysaccharide-induced shock, suggesting
an anti-inﬂammatory role for p50/p65 heterodimers36.
Interestingly, p50-null mice with normal p65 genes showed
spontaneous airspace enlargement with concomitant increases in
the phosphorylation, acetylation (Lys310) and DNA-binding
activity of p65 in the lung, which were further increased after
CS exposure37. These animal studies indicate the importance of
the transactivation function of acetylated p65 for the pro-
inﬂammatory activity of NF-kB. In line with this notion, our
results indicate that ProT has an important role in the acetylation
and activation of NF-kB, particularly upon CS exposure, within
the pathogenesis of emphysema. Nevertheless, the clinical
signiﬁcance of the anti-inﬂammatory role of NF-kB in
emphysema has yet to be established.
Besides inﬂammation, oxidative stress also has an important
role in CS-mediated emphysema. Nrf2 is a nuclear transcription
factor that controls the expression and coordinated induction of
defensive genes encoding detoxifying enzymes and antioxidant
proteins. Nrf2 knockout mice exhibited enhanced susceptibility to
CS-induced emphysema38. ProT can regulate the Nrf2-Keap1
(inhibitor of Nrf2, also known as INrf2) system, suggesting that it
has a role in oxidative stress defense39,40. ProT can dissociate
the Nrf2–Keap1 complex by interaction with Keap1, thus
upregulating the expression of Nrf2-dependent oxidative stress-
protecting genes39. A seemingly conﬂicting report showed that
ProT can mediate the nuclear import of the INrf2/Cul3 Rbx1
complex to degrade nuclear Nrf2 and rapidly switch off the
activation of Nrf2 downstream gene expression40. These studies
suggest the potential involvement of ProT in the on/off switch of
Nrf2-Keap1 mechanisms. Furthermore, NF-kB can antagonize
the Nrf2-antioxidant response element pathway by both
depriving CBP from Nrf2 and promoting the recruitment of
HDACs to antioxidant response element, suggesting a possible
role for NF-kB in suppressing the expression of anti-
inﬂammatory genes41. However, the clinical relevance of the
interplay between ProT and NF-kB in the Nrf2–Keap1 system
remains to be determined. Whether overexpressed ProT in the
lungs of patients or mice with emphysema effects the expression
of Nrf2-dependent genes, particularly in response to CS, requires
further investigation.
ProT may exert differential effects depending on its cellular
localization. It not only functions in the nucleus as described here,
but also has a signiﬁcant anti-apoptotic role in the cytoplasm by
binding to cytochrome c and hence inhibiting cytochrome
c-induced caspase activation and apoptosis42,43, as well as by
directly inhibiting the apoptosome, an important complex in the
execution of apoptosis44. Additionally, extracellular ProT has a
neuroprotective role in cerebral ischemia-induced damage45,46.
The cytoprotective function of ProT appears to be in opposition
to our results, demonstrating the involvement of ProT in
oxidative stress-induced lung tissue injury, a mechanism that
contributes to the pathogenesis of CS-mediated emphysema. We
show that ProT is overexpressed in the nucleus of
emphysematous tissues from clinical patients and ProT
transgenic mice and in a mouse model of CS-induced
emphysema. The nuclear role of ProT is more closely related
than its cytoplasmic or extracellular role to the elevation of
acetylated chromatin and NF-kB transactivation found in the
emphysematous lung, further supporting the clinical relevance of
ProT in terms of emphysema pathogenesis.
Our results from patients with emphysema and animal models
indicate that excess ProT in the lung contributes to the
development of emphysema and that CS exposure exacerbates
disease severity by further promoting ProT expression. Our data
reveal a novel function of ProT of inhibiting HDAC expression
and activity. We also provide evidence linking ProT with NF-kB
in emphysema. Our ﬁndings may further illuminate how CS
mediates the chromatin remodelling of pro-inﬂammatory genes
and reduction of HDAC activity in the development of
emphysema. As COPD is poorly responsive to the anti-
inﬂammatory actions of corticosteroids due to reduced HDAC
activity2,47,48, ProT may serve as a novel therapeutic target to
overcome this major therapeutic barrier. Oxidative stress
triggered by components of CS can induce ERK-dependent
phosphorylation of c-myc, hence promoting the stability and
accumulation of c-myc49,50. As ProT is a target gene of c-myc51,
it is tempting to postulate that CS-induced ProT overexpression
in emphysema may be attributable, in part, to the activation of
c-myc. Further studies are required to elucidate the mechanism
of CS-mediated upregulation of ProT in the pathogenesis of
emphysema.
Methods
Clinical samples and mice. Clinical samples were collected from 20 patients with
a diagnosis of emphysema who underwent surgery at the Thoracic Division,
Department of Surgery, National Cheng Kung University (NCKU) Hospital.
Among them, eight patients with severe to very severe emphysema underwent lung
volume reduction surgery or lung transplantation, and the remainder with mild-to-
moderate emphysema received a bullectomy or wedge resection for the treatment
of pneumothorax. The severity of emphysema was spirometrically classiﬁed
according to the criteria of the Global initiative for chronic obstructive lung disease.
Eight of twelve patients with mild or moderate emphysema and seven of eight
patients with severe and very severe emphysema were smokers. The clinical
characteristics of COPD patients are summarized in Supplementary Table S1. The
samples that served as ‘normal’ controls were from the non-tumour parts of the
resected lobes of four patients who were cigarette smokers without COPD and who
had undergone surgery for lung cancer. Informed consent was obtained from all
subjects, and the experimental protocol was approved by the Human Experiment
and Ethics Committee, NCKU Hospital. ProT transgenic mice were generated and
screened as described previously19. The experimental protocol adhered to the rules
of the Animal Protection Act of Taiwan and was approved by the Laboratory
Animal Care and Use Committee of NCKU.
Cells and plasmids. Human A549 lung adenocarcinoma cells and murine MLE 12
lung epithelial cells were originally obtained from American Type Culture Col-
lection (ATCC). Human 293T embryonic kidney cells were obtained from the
National RNAi Core Facility, Academia Sinica, Taiwan. The commercially available
plasmids that were used in this study included pCMVb p300 HA delta33, which
encodes human p300 mutant protein lacking amino acids 1737–1836; pcDNA3.1-
HDAC1-Flag; pcDNA3.1-HDAC3-Flag; and pcDNA3-cFlag-RelA, each of which
was purchased from Addgene; as well as pHM6-lacZ (Roche), pNF-kB-Luc
(Clontech), pTK-Renilla (Promega) and pCMV-Tag2B (Stratagen).
The plasmids used in this study were constructed as follows. The cDNA frag-
ment of mouse ProT was excised from pJ6O-ProT19 by digestion with HindIII and
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EcoRI and then cloned into the HindIII/EcoRI sites of pcDNA3.1 and pcDNA3.1/
myc-His (Invitrogen) to generate pcDNA3.1-ProT and pcDNA3.1/ProT-myc/His,
respectively. Subsequently, pcDNA3.1-ProT was digested with PmeI and EcoRI to
excise the ProT coding sequence, which was then ligated into the PmeI/EcoRI sites
of pWPXL52 to replace the GFP gene to yield pWPXL-ProT. An IRES-GFP
fragment was excised from PWPI by EcoRI digestion and subcloned into the EcoRI
site of pWPXL-ProT to generate pWPXL-ProT-IRES-GFP. The pcDNA3.1-ProT
was digested with HindIII and PmeI and subcloned into the the HindIII/SmaI sites
of pEGFP-C1 (Clontech) to generate a GFP-tagged ProT expression plasmid
(pEGFP-C1-ProT). Moreover, the CMV promoter-driven Flag-tagged fusion
cassette was excised from pCMV-tag2B by NdeI and BamHI digestion and cloned
into the NdeI/BglII sites of pEGFP-C1-ProT to replace the GFP coding sequence,
yielding a Flag-tagged ProT expression plasmid (pCMV-tag2B-ProT). The cDNA
fragment (1,591 bp) of human HDAC2 was obtained from the reverse
transcriptase-polymerase chain reaction (RT–PCR) ampliﬁcation of mRNA from
293T cells with forward primer 50-ACTATCGCCCCCACGGATCCCTCA-30 and
the reverse primer 50-TTTCCAATTGAGGGGTTGCTGAGCTGTTCTG-30 in
which a BamHI site and an MfeI site (underlined) were introduced onto the 50-end
and the 30-end, respectively. The resulting PCR amplicons were digested with
BamHI and MfeI and subcloned into the BamHI/EcoRI sites of pCMV-tag4C
(Stratagen) to generate a Flag-tagged HDAC2 expression plasmid (pCMV-tag4C-
HDAC2).
Lentiviral vectors. Recombinant lentiviruses coexpressing ProT and enhanced
green ﬂuorescent protein (EGFP) or expressing either EGFP-tagged ProT or EGFP
alone were individually produced by the transient transfection of 293T cells with
pWPXL-ProT-IRES-GFP, pWPXL-EGFP-ProT and pWPT, along with the
packaging construct psPAX2 and the VSV-G expression plasmid pMD2G53. For
the ProT knockdown experiments, pLKO.1-puro-based lentiviral vectors including
stem-loop cassettes encoding shRNA for human ProT (TRCN0000138110,
0000135421, 0000133816, 0000134223 and 0000138750; designated ProT shRNA-
1–5), mouse ProT (TRCN0000125359, 0000125360, 0000125361, 0000125362 and
0000125363; designated ProT shRNA 12–15) and luciferase (TRCN 0000072246;
designated Luc shRNA) were used. On the basis of real-time RT–PCR analysis, the
most efﬁcient shRNA for knockdown of human ProT (shRNA-2) or mouse ProT
(shRNA 15) was selected for lentiviral production. Lentiviruses were produced and
titrated as previously described52.
CSE and animal models. The CSE was prepared as described with slight mod-
iﬁcations21,22,54. One cigarette (Marlboro, Philip Morris USA Inc.) was burned,
and the smoke was imported to a vessel containing saline (3ml per cigarette) using
a vacuum pump. The CSE-saline solution was freshly prepared and sterilized via
ﬁltration through a 0.22-mm Millipore ﬁlter for each injection. Six-week-old male
FVB mice or ProT HET transgenic mice were injected intraperitoneally with 0.5ml
of CSE-saline or saline twice a week for 6 weeks. The mice were killed, and the lung
tissue sections were subjected to H&E staining and examined for alveolar airspace
enlargement. Average airspace area was calculated by dividing the total airspace
by the total number of alveoli using MetaMorph software (Universal Imaging
Corp.)55. For the in vivo knockdown experiments, six-week-old FVB mice were
intratracheally injected with lentiviral vectors expressing shRNA speciﬁc to ProT or
Luc followed by intraperitoneal injections of CSE or saline twice a week for 6
weeks.
Immunological assays. For the immunohistochemical studies, 5-mm-thick sec-
tions of parafﬁn-embedded human or mouse lung tissue blocks were prepared. The
primary antibodies used included monoclonal antibodies against ProT (clone 2F11,
ascites ﬂuid)56,57 and polyclonal antibodies against HDAC1 (1:100, Santa Cruz),
HDAC2 (1:100, Santa Cruz), HDAC3 (1:100, Santa Cruz), acetylated-lysine (1:800,
Cell Signaling), acetylated-Lys310 NF-kB p65 (1:100, Genetex), MMP2 (1:50, Santa
Cruz) and MMP9 (1:50, Santa Cruz). Tissue sections were incubated with primary
antibodies at 4 C overnight followed by incubation with horseradish peroxidase-
conjugated goat anti-mouse, goat anti-rabbit or donkey anti-goat IgG (1:200,
Jackson) at room temperature for 2 h. Negative controls included sections stained
with mouse universal negative control (Dako) and isotype control IgG (Santa
Cruz). The reactivity was visualized with aminoethyl carbazole (red colour, Zymed)
and counterstained with hematoxylin.
Immunoblotting and immunoprecipitation were performed using standard
methods. As ProT is a highly acidic protein and is poorly retarded by the
nitrocellulose membrane at standard electrotransfer conditions, protein samples
were transferred by an acidic transfer method onto a PVDF membrane (Millipore)
to immobilize ProT57. The primary antibodies used for immunoblotting included
antibodies against ProT (clone 2F11), acetylated-lysine (1:1000, Cell Signaling),
HDAC1 (1:1000, Santa Cruz), HDAC2 (1:1000, Santa Cruz), HDAC3 (1:1000,
Santa Cruz), histone H1 (1:2000, Santa Cruz), acetylated-histone H1 (1:1000,
Genetex), histone H3 (1:2000, Santa Cruz), acetylated-histone H3 (1:1000, Cell
Signaling), NF-kB p65 (1:1000, Santa Cruz), acetylated-Lys310 NF-kB p65 (1:1000,
Genetex), p300 (1:500, Santa Cruz) and b-actin (1:10,000, Abcam). horseradish
peroxidase-conjugated goat anti-mouse, goat anti-rabbit or donkey anti-goat
IgG (Jackson) were used as secondary antibodies where appropriate, and
protein–antibody complexes were detected by the ECL system (Millipore) and
visualized with a Biospectrum AC imaging system (UVP). Images of full-length
blots are shown in Supplementary Fig. S6. For immunoﬂuorescence, the cells were
incubated with ProT (clone 2F11) and acetylated-lysine (1:800, Cell Signaling)
antibodies and subsequently incubated with Alexa Fluor 594-conjugated goat anti-
mouse IgG (Invitrogen) and FITC-conjugated goat anti-rabbit IgG (KPL). The
nuclei were counterstained with DAPI (Sigma-Aldrich). Fluorescence signals were
examined by ﬂuorescence microscopy.
RT–PCR analysis. Total RNA was isolated from the lung tissue of transgenic mice
or lentivirus-transduced cells using QuickGene RNA tissue or a cultured cell kit
(Fujiﬁlm), and 2 mg of RNA was used for cDNA synthesis using a reverse iT ﬁrst-
strand synthesis kit (Thermo) according to the manufacturer’s instructions. The
following primers were used for RT–PCR: human and mouse ProT, 50-AAGGAG
AAGAAGGAAGTTGTGGA-30 (forward) and 50-CTACCTCATTGTCAGCCT
CCTG-30 (reverse); mouse MMP2, 50-GAGGATACCCCAAGCCACTGA-30
(forward) and 50-CCAGCCAGTCTGATTTGATGCT-30 (reverse); mouse MMP9,
50-TAAAACGCAGCTCAGTAACAGTCCG-30 (forward) and 50-TGGAATCCTG
TGGCATCCATGAAAC-30 (reverse); human MMP2, 50-CTGGAGATACAATG
AGGTGAAGAAG-30 (forward) and 50-AAGGCAGTGGAGAGGAAGGG-30
(reverse); human MMP9, 50-GCATAAGGACGACGTGAATGGC-30 (forward)
and 50-GGACTCAAAGGCACAGTAGTGG-30 (reverse); human and mouse
GAPDH, 50-ACTTCAACAGCGACACCCACT-30 (forward) and 50-GCCAAATT
CGTTGTCATACCAG-30 (reverse). The PCR products were separated by 1%
agarose gel electrophoresis.
ChIP assay. ChIP was performed using the EZ-CHIP kit (Millipore). Brieﬂy, the
proteins were formaldehyde (1%) crossed-linked to chromatin in 293T cells that
had been transfected with Flag- or GFP-tagged ProT or with Flag-tagged NF-kB
p65 plasmid DNA. The cell lysates were sonicated with alternating 30 s pulses 10
times by a sonicator (Microson XL2000, Misonix Inc., Farmingdale, NY, USA) to
shear DNA to lengths between 500 and 1,000 bp followed by immunoprecipitation
with anti-Flag-M2 beads (Sigma-Aldrich), or with anti-GFP (Santa Cruz) or anti-
IgG (Santa Cruz) antibodies in combination with protein A plus G sepharose
(Santa Cruz). The immunoprecipitates were washed and reverse cross-linked. PCR
was performed on the phenol–chloroform-extracted DNA to detect the NF-kB-
binding sites within the MMP2 and MMP9 promoters with speciﬁc primers as
described previously58,59. The PCR primers used in ChIP included MMP2,
50-GGTTCCAACGTCTCTAACG-30 (forward) and 50-CAGATGATCAGCCA
CAATG-30 (reverse); MMP9, 50- AGTGGTAAGACATTTGCCCGA-30 (forward)
and 50-TGCAACACCCCCTCCCAGGTCAG-30 (reverse). The PCR products were
separated by 1% agarose gel electrophoresis.
Zymography. The enzymatic activities of MMP2 and MMP9 were determined by
gelatin zymography as previously described60. The conditioned medium collected
from the mouse embryonic ﬁbroblasts of ProT transgenic or NT mice was
electrophoresed on 10% SDS–PAGE gels containing 1mgml 1 gelatin (Sigma-
Aldrich) to assess MMP2 and MMP9 activity.
Statistical analysis. Statistical analyses were performed using SigmaStat 3.5
(Systat Software). Statistical signiﬁcance was assessed with Student’s t-test.
Correlations were measured using Pearson’s correlation coefﬁcient (r).
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